This federal contract award is for the pharmaceutical product ENBREL 25 MG/0.5 ML SYRINGE 0.5ML, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,483.78 and is a delivery order with a firm fixed price. The award date is December 3, 2024, and the ultimate completion date is December 4, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/4/25, 11:30 AM